Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Says Successful Clinical Development Of Pembrolizumab Biosimilar Fyb206

Feb 27 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

ZYDUS LIFESCIENCES - SUCCESSFUL CLINICAL DEVELOPMENT OF  PEMBROLIZUMAB BIOSIMILAR FYB206

ZYDUS LIFESCIENCES - ACHIEVEMENT CLEARS PATHWAY FOR NEAR-TERM BLA FILING WITH USFDA

Further company coverage: ZYDU.NS

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news